Liganded and unliganded activation of estrogen receptor and hormone replacement therapies
- 1 August 2011
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1812 (8), 1054-1060
- https://doi.org/10.1016/j.bbadis.2011.05.001
Abstract
No abstract availableKeywords
Funding Information
- eu (STREP EWA LSHM-CT-2005-518245, CRESCENDO LSHM-CT-2005-018652)
- NIH (RO1AG027713)
This publication has 101 references indexed in Scilit:
- c-Abl regulates estrogen receptor α transcription activity through its stabilization by phosphorylationOncogene, 2010
- Steroid receptor phosphorylation: Assigning function to site‐specific phosphorylationBioFactors, 2009
- OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) α and Affects ERα Transcriptional ActivityPublished by Elsevier BV ,2009
- Binding of estrogen receptor α/β heterodimers to chromatin in MCF-7 cellsJournal of Molecular Endocrinology, 2009
- Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation SitesMolecular & Cellular Proteomics, 2009
- Regulation of Estrogen Receptor α by the SET7 Lysine MethyltransferaseMolecular Cell, 2008
- Ligand-dependent switching of ubiquitin–proteasome pathways for estrogen receptorThe EMBO Journal, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000